Switch to:

Teva Pharmaceutical Industries EV-to-EBITDA

: 29.44 (As of Today)
View and export this data going back to 1990. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Teva Pharmaceutical Industries's enterprise value is $39,768 Mil. Teva Pharmaceutical Industries's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was $1,351 Mil. Therefore, Teva Pharmaceutical Industries's EV-to-EBITDA for today is 29.44.

NYSE:TEVA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -36.8   Med: 12.75   Max: 303.8
Current: 29.22

-36.8
303.8

During the past 13 years, the highest EV-to-EBITDA of Teva Pharmaceutical Industries was 303.80. The lowest was -36.80. And the median was 12.75.

NYSE:TEVA's EV-to-EBITDA is ranked lower than
80% of the 640 Companies
in the Drug Manufacturers industry.

( Industry Median: 12.88 vs. NYSE:TEVA: 29.22 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-06-07), Teva Pharmaceutical Industries's stock price is $12.84. Teva Pharmaceutical Industries's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was $-0.76. Therefore, Teva Pharmaceutical Industries's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Teva Pharmaceutical Industries EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Teva Pharmaceutical Industries Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.69 40.27 -3.62 281.68 27.87

Teva Pharmaceutical Industries Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.83 -19.95 -16.53 27.87 26.74

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Teva Pharmaceutical Industries EV-to-EBITDA Distribution

* The bar in red indicates where Teva Pharmaceutical Industries's EV-to-EBITDA falls into.



Teva Pharmaceutical Industries EV-to-EBITDA Calculation

Teva Pharmaceutical Industries's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=39768.120/1351
=29.44

Teva Pharmaceutical Industries's current Enterprise Value is $39,768 Mil.
Teva Pharmaceutical Industries's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was -194 (Jun. 2019 ) + 332 (Sep. 2019 ) + 623 (Dec. 2019 ) + 590 (Mar. 2020 ) = $1,351 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Teva Pharmaceutical Industries  (NYSE:TEVA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Teva Pharmaceutical Industries's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12.84/-0.76
=

Teva Pharmaceutical Industries's share price for today is $12.84.
Teva Pharmaceutical Industries's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was -0.63 (Jun. 2019 ) + -0.29 (Sep. 2019 ) + 0.1 (Dec. 2019 ) + 0.06 (Mar. 2020 ) = $-0.76.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Teva Pharmaceutical Industries EV-to-EBITDA Related Terms


Teva Pharmaceutical Industries EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)